Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 -0.825M
December 31, 2025 -0.251M
September 30, 2025 -1.826M
June 30, 2025 0.13M
March 31, 2025 -1.375M
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 -5.024M
March 31, 2023 0.00
December 31, 2022 -0.012M
September 30, 2022 0.00
June 30, 2022 -0.017M
March 31, 2022 0.00
Date Value
December 31, 2021 -0.085M
September 30, 2021 -0.037M
June 30, 2021 -0.133M
March 31, 2021 -0.027M
December 31, 2020 -0.159M
September 30, 2020 -24.27M
June 30, 2020 -0.154M
March 31, 2020 -0.001M
December 31, 2019 -0.145M
September 30, 2019 -0.365M
June 30, 2019 -164.62M
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. -66.85M
IRulya Therapeutics, Inc. -108.99M
Climb Bio, Inc. -103.70M
PepGen Inc. 0.175M
Bridgebio Oncology Therapeutics, Inc. -0.037M